Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4)

Leonie Voorwerk; Maarten Slagter; Hugo M. Horlings; Karolina Sikorska; Koen K. van de Vijver; Michiel de Maaker; Iris Nederlof; Roelof J.C. Kluin; Sarah Warren; Su Fey Ong; Terry G. Wiersma; Nicola S. Russell; Ferry Lalezari; Philip C. Schouten; Noor A.M. Bakker; Steven L.C. Ketelaars; Dennis Peters; Charlotte A.H. Lange; Erik van Werkhoven; Harm van Tinteren; Ingrid A.M. Mandjes; Inge Kemper; Suzanne Onderwater; Myriam Chalabi; Sofie Wilgenhof; John B.A.G. Haanen; Roberto Salgado; Karin E. de Visser; Gabe S. Sonke; Lodewyk F.A. Wessels; Sabine C. Linn; Ton N. Schumacher; Christian U. Blank; Marleen Kok

doi:10.1038/s41591-019-0520-5

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4)

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings, Karolina Sikorska, Koen K. van de Vijver, Michiel de Maaker, Iris Nederlof, Roelof J.C. Kluin, Sarah Warren, Su Fey Ong, Terry G. Wiersma, Nicola S. Russell, Ferry Lalezari, Philip C. Schouten, Noor A.M. Bakker, Steven L.C. Ketelaars, Dennis Peters, Charlotte A.H. Lange, Erik van Werkhoven, Harm van TinterenIngrid A.M. Mandjes, Inge Kemper, Suzanne Onderwater, Myriam Chalabi, Sofie Wilgenhof, John B.A.G. Haanen, Roberto Salgado, Karin E. de Visser, Gabe S. Sonke, Lodewyk F.A. Wessels, Sabine C. Linn, Ton N. Schumacher, Christian U. Blank, Marleen Kok

Research output: Contribution to journal › Comment/debate

5 Citations (Scopus)

Abstract

In the version of this article originally published, there was an error in Fig. 3j. A label on the heatmap read “TGF-α signaling via NF-κB”. It should have read “TNF-α signaling via NF-κB”. The error has been corrected in the HTML and PDF versions of this article.

Original language	English
Pages (from-to)	1175
Number of pages	1
Journal	Nature Medicine
Volume	25
Issue number	7
DOIs	https://doi.org/10.1038/s41591-019-0520-5
Publication status	Published - 1 Jul 2019
Externally published	Yes

Access to Document

10.1038/s41591-019-0520-5

Fingerprint

Dive into the research topics of 'Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4)'. Together they form a unique fingerprint.

Cite this

Voorwerk, L., Slagter, M., Horlings, H. M., Sikorska, K., van de Vijver, K. K., de Maaker, M., Nederlof, I., Kluin, R. J. C., Warren, S., Ong, S. F., Wiersma, T. G., Russell, N. S., Lalezari, F., Schouten, P. C., Bakker, N. A. M., Ketelaars, S. L. C., Peters, D., Lange, C. A. H., van Werkhoven, E., ... Kok, M. (2019). Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4). Nature Medicine, 25(7), 1175. https://doi.org/10.1038/s41591-019-0520-5

@article{2e5ce0452a9642f6842c88f4940e98c6,

title = "Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4)",

abstract = "In the version of this article originally published, there was an error in Fig. 3j. A label on the heatmap read “TGF-α signaling via NF-κB”. It should have read “TNF-α signaling via NF-κB”. The error has been corrected in the HTML and PDF versions of this article.",

author = "Leonie Voorwerk and Maarten Slagter and Horlings, {Hugo M.} and Karolina Sikorska and {van de Vijver}, {Koen K.} and {de Maaker}, Michiel and Iris Nederlof and Kluin, {Roelof J.C.} and Sarah Warren and Ong, {Su Fey} and Wiersma, {Terry G.} and Russell, {Nicola S.} and Ferry Lalezari and Schouten, {Philip C.} and Bakker, {Noor A.M.} and Ketelaars, {Steven L.C.} and Dennis Peters and Lange, {Charlotte A.H.} and {van Werkhoven}, Erik and {van Tinteren}, Harm and Mandjes, {Ingrid A.M.} and Inge Kemper and Suzanne Onderwater and Myriam Chalabi and Sofie Wilgenhof and Haanen, {John B.A.G.} and Roberto Salgado and {de Visser}, {Karin E.} and Sonke, {Gabe S.} and Wessels, {Lodewyk F.A.} and Linn, {Sabine C.} and Schumacher, {Ton N.} and Blank, {Christian U.} and Marleen Kok",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature America, Inc.",

year = "2019",

month = jul,

day = "1",

doi = "10.1038/s41591-019-0520-5",

language = "English",

volume = "25",

pages = "1175",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Publishing Group",

number = "7",

}

Voorwerk, L, Slagter, M, Horlings, HM, Sikorska, K, van de Vijver, KK, de Maaker, M, Nederlof, I, Kluin, RJC, Warren, S, Ong, SF, Wiersma, TG, Russell, NS, Lalezari, F, Schouten, PC, Bakker, NAM, Ketelaars, SLC, Peters, D, Lange, CAH, van Werkhoven, E, van Tinteren, H, Mandjes, IAM, Kemper, I, Onderwater, S, Chalabi, M, Wilgenhof, S, Haanen, JBAG, Salgado, R, de Visser, KE, Sonke, GS, Wessels, LFA, Linn, SC, Schumacher, TN, Blank, CU & Kok, M 2019, 'Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4)', Nature Medicine, vol. 25, no. 7, pp. 1175. https://doi.org/10.1038/s41591-019-0520-5

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4). / Voorwerk, Leonie; Slagter, Maarten; Horlings, Hugo M. et al.
In: Nature Medicine, Vol. 25, No. 7, 01.07.2019, p. 1175.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Publisher Correction

T2 - Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4)

AU - Voorwerk, Leonie

AU - Slagter, Maarten

AU - Horlings, Hugo M.

AU - Sikorska, Karolina

AU - van de Vijver, Koen K.

AU - de Maaker, Michiel

AU - Nederlof, Iris

AU - Kluin, Roelof J.C.

AU - Warren, Sarah

AU - Ong, Su Fey

AU - Wiersma, Terry G.

AU - Russell, Nicola S.

AU - Lalezari, Ferry

AU - Schouten, Philip C.

AU - Bakker, Noor A.M.

AU - Ketelaars, Steven L.C.

AU - Peters, Dennis

AU - Lange, Charlotte A.H.

AU - van Werkhoven, Erik

AU - van Tinteren, Harm

AU - Mandjes, Ingrid A.M.

AU - Kemper, Inge

AU - Onderwater, Suzanne

AU - Chalabi, Myriam

AU - Wilgenhof, Sofie

AU - Haanen, John B.A.G.

AU - Salgado, Roberto

AU - de Visser, Karin E.

AU - Sonke, Gabe S.

AU - Wessels, Lodewyk F.A.

AU - Linn, Sabine C.

AU - Schumacher, Ton N.

AU - Blank, Christian U.

AU - Kok, Marleen

PY - 2019/7/1

Y1 - 2019/7/1

N2 - In the version of this article originally published, there was an error in Fig. 3j. A label on the heatmap read “TGF-α signaling via NF-κB”. It should have read “TNF-α signaling via NF-κB”. The error has been corrected in the HTML and PDF versions of this article.

AB - In the version of this article originally published, there was an error in Fig. 3j. A label on the heatmap read “TGF-α signaling via NF-κB”. It should have read “TNF-α signaling via NF-κB”. The error has been corrected in the HTML and PDF versions of this article.

UR - http://www.scopus.com/inward/record.url?scp=85068055159&partnerID=8YFLogxK

U2 - 10.1038/s41591-019-0520-5

DO - 10.1038/s41591-019-0520-5

M3 - Comment/debate

C2 - 31209337

AN - SCOPUS:85068055159

SN - 1078-8956

VL - 25

SP - 1175

JO - Nature Medicine

JF - Nature Medicine

IS - 7

ER -

Voorwerk L, Slagter M, Horlings HM, Sikorska K, van de Vijver KK, de Maaker M et al. Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial (Nature Medicine, (2019), 25, 6, (920-928), 10.1038/s41591-019-0432-4). Nature Medicine. 2019 Jul 1;25(7):1175. doi: 10.1038/s41591-019-0520-5